Sam Mansour, MD
Ophthalmology · Warrenton, VANPI 1376506873
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $37,650 of the $49,427 with a category attached, or 76.2%. Iridex Corporation accounts for 76.4% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2024 at $22,364 and has fallen 87.3% since, to $2,846 in 2025. Among ophthalmology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $377.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Iridex Corporation$38K
- Alimera Sciences, Inc.$3K
- Eyepoint US, Inc.$3K
- Onmark, Inc.$2K
- Apellis Pharmaceuticals, Inc.$470
- Regeneron Healthcare Solutions, Inc.$429
- plus $3K from 23 others
Across 17 payments — averaging $2723.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alimera Sciences, Inc.$20K
- Astellas Pharma Global Development$18K
- ANI Pharmaceuticals, Inc.$6K
- Eyepoint US, Inc.$3K
What the payments were for
- Consulting fees$37,65076%
- Speaking & faculty fees$3,4367%
- Travel & lodging$3,3137%
- Food & beverage$5,00910%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Iridex Corporation | 16 | $37,778 |
| Alimera Sciences, Inc. | 6 | $3,346 |
| Eyepoint US, Inc. | 9 | $2,664 |
| Onmark, Inc. | 9 | $1,906 |
| Apellis Pharmaceuticals, Inc. | 10 | $470 |
| Regeneron Healthcare Solutions, Inc. | 12 | $429 |
| Astellas Pharma US Inc | 9 | $414 |
| Integra Lifesciences Corporation | 4 | $335 |
| Genentech USA, Inc. | 15 | $303 |
| Dutch Ophthalmic, USA | 1 | $274 |
| Notal Vision, Inc. | 2 | $236 |
| Bausch & Lomb Americas Inc. | 6 | $154 |
| Polynovo North America LLC | 1 | $150 |
| AbbVie | 6 | $148 |
| Novartis | 4 | $141 |
| Biotissue Holdings Inc. | 1 | $137 |
| Coherus Oncology, Inc. | 4 | $123 |
| Biogen | 4 | $79 |
| Topcon Healthcare, Inc. | 1 | $69 |
| ANI Pharmaceuticals, Inc. | 2 | $57 |
| US Oncology Corporate, Inc. | 1 | $39 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $28 |
| Sandoz | 1 | $25 |
| Harrow Eye, LLC | 1 | $23 |
| Thrombogenics, Inc. | 1 | $22 |
| Genentech, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Spark Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iluvien$3,200
- EYP-1901$2,599
- INTEGRA$841
- INTEGRA DERMAL REGENERATION TEMPLATE$280
- PRIMATRIX$280
- EVA, combined machine$274
- TISSUEBLUE$274
- Izervay$152
- Prokera$137
- EYLEA$132
How this compares
$49,427 in reported general payments places this provider in the 95th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 106 | $4,384 |
| Brimonidine Tartrate | 28 | $2,073 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $1,857 |
| Ketorolac Tromethamine | 63 | $1,643 |
| Latanoprost | 98 | $1,181 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 56 | $1,082 |
| Ofloxacin | 30 | $527 |
| ErythromycinErythromycin Base | 30 | $309 |
| Timolol Maleate | 24 | $181 |
| Dorzolamide Hcl | 25 | $78 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Warrenton
- Ethnie JonesRichmond$2M
- Elizabeth Yeu-LinNorfolk$1.7M
- John SheppardNorfolk$1.1M
- Constance OkekeNorfolk$800K
- Marc OdrichCharlottesville$497K
- Jayakrishna AmbatiCharlottesville$116K
- Thomas JolyNorfolk$95K
- Stephen ScoperNorfolk$88K
- Leonard RappaportPortsmouth$85K
- Soheila RostamiReston$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.